Targeting PEG10 as a novel therapeutic approach to overcome CDK4/6 inhibitor resistance in breast cancer

Targeting PEG10 as a novel therapeutic approach to overcome CDK4/6 inhibitor resistance in breast cancer

Abstract Background Breast cancer is the global leading cancer burden in women and the hormone receptor-positive (HR+) subtype is a major part of breast cancer. Though cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitors are highly effective therapy for HR+ subtype, acquired resistance is inevitable...

पूर्ण विवरण

ग्रंथसूची विवरण
मुख्य लेखकों: Nar Bahadur Katuwal, Min Sil Kang, Mithun Ghosh, Sa Deok Hong, Yeong Gyu Jeong, Seong Min Park, Seul-Gi Kim, Joohyuk Sohn, Tae Hoen Kim, Yong Wha Moon
स्वरूप: लेख
भाषा:English
प्रकाशित: BMC 2023-11-01
श्रृंखला:Journal of Experimental & Clinical Cancer Research
विषय:
CDK4/6
ASO
PEG10
HR+ breast cancer
Drug resistance
ऑनलाइन पहुंच:https://doi.org/10.1186/s13046-023-02903-x

इंटरनेट

https://doi.org/10.1186/s13046-023-02903-x

समान संसाधन